Omeprazole (Generic) Normon (Omeprazole Sodium)

Omeprazole, the active ingredient in Omeprazole (Generic) Normon, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Omeprazole (Generic) Normon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazole (Generic) Normon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton pump inhibitor that acts on gastric acid secretion pathways. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates. - NSAID‑associated ulcer prophylaxis: lowers the risk of ulcer development in patients requiring chronic NSAID therapy.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Constipation: occasional reports. - Abdominal pain or discomfort: mild. - Nausea or vomiting: transient. - Flatulence: occasional.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis, angioedema): require immediate medical attention. - Clostridioides difficile‑associated colitis: may present with watery diarrhoea. - Low magnesium levels (hypomagnesemia): can cause muscle cramps or cardiac arrhythmia. - Bone fractures (hip, wrist, spine): associated with long‑term use. - Acute interstitial nephritis: renal impairment signs. - Liver enzyme elevations: monitor hepatic function if persistent.

Omeprazole should be used with consideration of several safety aspects: - Pregnancy: limited data, use only if clearly needed. - Breastfeeding: small amounts excreted in milk; weigh benefits against risks. - Elderly patients: monitor for bone fracture risk with prolonged therapy. - Renal or hepatic impairment: dose adjustment may be required. - Concomitant use with drugs that require gastric acidity for absorption: assess necessity. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, consider alternative therapy. - Atazanavir or other protease inhibitors: markedly decreased absorption. - Warfarin: potential increase in INR, monitor coagulation parameters.

Moderate Interactions (Monitor Closely): - Methotrexate: increased serum levels, especially with high‑dose regimens. - Digoxin: modest rise in serum concentration. - Phenytoin: decreased plasma concentrations. - Ketoconazole and other azole antifungals: reduced absorption, may need dose adjustment.